Quorum Review Launches New Site Enrollment Service
Quorum Review IRB, industry member in central IRB services, unveils today a Site Enrollment Service as part of their 2013 platform of ethics review services.
Quorum’s Site Enrollment Service allows customers to delegate the IRB startup component of clinical research for minimal cost. Quorum Review Site Support personnel will reach out to the research sites identified by the sponsor/CRO to support those sites through the submission process. The sponsor/CRO will receive on-going status updates.
As Quorum Review CEO Cami Gearhart, JD, explains, this service provides a new level of site management within the study start up process. “Site start-up that is quick and efficient is mission-critical for our customers. By leveraging the expertise of our site support team, we can help our customers streamline the collection of study start-up documentation.”
While the service is focused on the initial site submission phase to the IRB, clients have access to the service any time a new site is considered for participation in a central study. More information on the new Site Enrollment Service and all of Quorum’s ethics review services can be found at www.quorumreview.com.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
